If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 BPH

BPH Surgical Approaches Compared

May 19, 2012

Transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH) is associated with an increased risk of complications but a significantly lower risk of repeat BPH surgery compared to minimally-invasive surgeries, according to a poster presentation at the American Urological Association 2012 annual meeting.
 

BPH Surgery Complication Rates Underestimated

April 30, 2012

PARIS—Complication rates after surgery for benign prostatic hyperplasia (BPH) are higher in real clinical practice than in clinical trials.
 

Open Prostatectomy, TURP Are the Most Common BPH Surgeries

April 25, 2012

Despite the emergence of new surgical techniques to treat benign prostatic hyperplasia (BPH), open prostatectomy (OP) and monopolar transurethral resection of the prostate (TURP) remain the procedures used most by urologists, according to a recent survey.
 

Prostatic Artery Embolization Eases BPH Symptoms

March 27, 2012

SAN FRANCISCO—Benign prostatic hyperplasia (BPH) may be safely treated with prostatic artery embolization (PAE), according to a new study presented at the 37th Annual Scientific Meeting of the Society of Interventional Radiology (SIR).
 

NSAIDs Do Not Protect Against BPH/LUTS

March 21, 2012

Recent use of nonsteroidal anti-inflammatory agents (NSAIDs) do not protect against development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), a new study concluded.
 

Finasteride Prevents BPH, Study Finds

March 14, 2012

Finasteride use decreases the risk of clinical benign prostatic hyperplasia (BPH), according to researchers.
 

Severe Post-Transplant LUTS May Be Predictable

March 02, 2012

QUEBEC CITY—Evaluation of lower urinary tract symptoms (LUTS) using validated questionnaires prior to renal transplantation (Tx) may predict which patients will experience significant LUTS after transplantation, researchers reported at the Canadian Society of Transplantation annual meeting.
 

PDE-5 Inhibitors Improve LUTS in Men

February 26, 2012

PARIS—Phosphodiesterase-5 (PDE-5) inhibitors significantly improve lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and can be considered as an alternative treatment for BPH-related LUTS in men with or without erectile dysfunction, researchers reported at the 27th Annual Congress of the European Association of Urology.
 

Metabolic Syndrome Raises BPH Risk

February 25, 2012

PARIS—Metabolic syndrome increases a man's risk of developing benign prostatic hyperplasia (BPH) and the risk of prostatic inflammation in men who have BPH, according to reports at the 27th Annual Congress of the European Association of Urology.
 

Prostatic Urethral Lift Relieves Lower Urinary Tract Symptoms

January 03, 2012

Use of a prostatic urethral lift procedure, a minimally invasive treatment for lower urinary tract symptoms (LUTS) resulting from benign prostatic hyperplasia (BPH), preserves sexual function, according to a study published online ahead of print in The Journal of Sexual Medicine.
 

Study: Electromagnetic Treatment Improves BPH

December 19, 2011

Radiofrequency pulsed electromagnetic fields (EMF) may provide a non-invasive treatment for benign prostatic hyperplasia (BPH), researchers reported.
 

Epinephrine Can Cut TURP-Related Blood Loss

December 13, 2011

Epinephrine injected into the prostate can be used to decrease blood loss during transurethral resection of the prostate (TURP), according to researchers.
 

HoLEP's Benefits As BPH Treatment Durable Out to 10 Years

October 31, 2011

Holmium laser enucleation of the prostate (HoLEP) is an effective treatment for benign prostatic hyperplasia (BPH) that has long-term durable clinical outcomes, researchers concluded.
 

Saw Palmetto No More Effective than Placebo for BPH

October 14, 2011

Saw palmetto fruit extracts are widely used to treat lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH), but a new study shows that these extracts are no better than placebo at easing symptoms, according to investigators.
 

Erectile Dysfunction Drug Approved as BPH Treatment

October 08, 2011

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men with both erectile dysfunction (ED) and BPH.
 

PCa More Likely in BPH Sufferers

October 01, 2011

Prostate cancer (PCa) is more likely to be diagnosed in men who have been hospitalized for clinical benign prostatic hyperplasia (BPH) or undergone surgery for the condition, according to a Danish study.
 

Higher CRP Levels Predict Residual Urgency in BPH Patients

August 31, 2011

GLASGOW—Serum C-reactive protein (CRP) levels, a marker of systemic inflammation, are associated with residual urgency after medical treatment for benign prostatic hyperplasia (BPH), according to new findings presented at the International Continence Society annual meeting.
 

Botulinum Toxin Injections Effective for BPH

August 30, 2011

GLASGOW—Intraprostatic injections of botulinum neurotoxin type A (BoNT-A) are a safe and effective treatment for benign prostatic hyperplasia (BPH), according to a study presented at the International Continence Society annual meeting.
 

Heavier Men Face Higher LUTS Risk

May 18, 2011

WASHINGTON, D.C.—Elderly men who are overweight or obese are at increased risk for developing lower urinary tract symptoms (LUTS), but those who engage in a relatively high level of physical activity or daily walking for exercise have a reduced risk, data show.
 

Severe Adverse BPH Outcomes Persist

May 18, 2011

WASHINGTON, D.C.—Severe adverse outcomes of benign prostatic hyperplasia (BPH) persist despite widespread use of oral therapies, according to a study presented at the American Urological Association 2011 annual meeting.
 

Overweight Young Men Face High Risk of Enlarged Prostates

May 17, 2011

WASHINGTON, D.C.—Overweight young men are more likely than normal-weight men to develop an enlarged prostate later in life, researchers reported.
 

Modest Weight Loss Does Not Prevent LUTS

May 17, 2011

WASHINGTON, D.C.—Although obesity has been linked with lower urinary tract symptoms (LUTS) in aging men, modest weight loss may not prevent onset or progression of LUTS in this population, new findings presented at the American Urological Association 2011 annual meeting suggest.
 

Statins May Improve Urologic Symptoms in Men

May 17, 2011

WASHINGTON, D.C.—Statin use may decrease the occurrence of lower urinary tract symptoms (LUTS) among men, but not women, researchers reported at the American Urological Association 2011 annual meeting.
 

African-American Men Less Likely to Receive BPH Treatment

May 17, 2011

WASHINGTON, D.C.—African American men are less likely to receive treatment for benign prostatic hyperplasia (BPH) compared with other races, according to findings presented at the American Urological Association 2011 annual meeting.
 

Outpatient BPH Procedure Works

March 29, 2011

CHICAGO—Prostatic artery embolization (PAE), a new outpatient interventional radiology treatment that blocks the blood supply to enlarged prostate glands, achieves outcomes similar to those of transurethral resection of the prostate (TURP), according to Portuguese researchers.
 

Botulinum Toxin Eases LUTS in Men

March 22, 2011

VIENNA—Botulinum toxin type A (BTA) injected into the prostate may be a safe and effective treatment for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), according to preliminary study results presented here at the 26th Annual Congress of the European Association of Urology.
 

Novel Cause of BPH, PCa Proposed

March 22, 2011

VIENNA—Benign prostatic hyperplasia (BPH) and prostate cancer could be the result a previously unrecognized route of free testosterone flow from the testes to the prostate, according to investigators.
 

Tadalafil Helps Men with Both ED and BPH-LUTS

March 20, 2011

VIENNA—Tadalafil can improve erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in men who suffer from both problems, data suggest.
 

AUA Updates BPH Guidelines

February 08, 2011

Updated American Urological Association (AUA) guidelines for treating benign prostatic hyperplasia (BPH) include recommendations that laboratory testing include a PSA test and a urinalysis to rule out infection or other causes of lower urinary tract symptoms (LUTS).
 

DHT Does Not Affect Prostate Growth

January 24, 2011

Dihydrotestosterone (DHT) treatment over two years does not halt prostate growth, according to study findings published in the Annals of Internal Medicine (2010;153:621-632).
 
Popular Topics
Acute Kidney Injury AKI Androgen Deprivation Anemia Benign Prostatic Hyperplasia Bladder Cancer BPH Cardiovascular Disease Chronic Kidney Disease Circumcision CKD CVD Dialysis End-stage Renal Disease Hemodialysis Overactive Bladder Prostate Cancer Renal Cell Carcinoma Reproductive Medicine Secondary Hyperparathyroidism Transplantation Urinary Incontinence Urinary Tract Infection Urology UTI

 

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions